AndroGel Lawsuit | AndroGel Testosterone Lawsuit | androgel class action lawsuit
AndroGel, a blockbuster testosterone treatment marketed by AbbVie, Inc. may be associated with an increased risk of heart attack, stroke and other life-threatening cardiovascular side effects in certain men. The U.S. Food & Drug Administration (FDA) launched a review of AndroGel and other low testosterone therapies in January 2014 after a number of studies raised concerns about their potential heart risks. In the wake of the FDA’s announcement, several AndroGel lawsuits were filed on behalf of men who allegedly suffered serious cardiovascular problem following treatment with the popular testosterone gel.
Men who used this testosterone medication may want to consider filing an AndroGel lawsuit if they suffered a heart attack, stroke or other cardiovascular event during treatment. The attorneys at Wright & Schulte LLC are committed to ensuring that the alleged victims of AndroGel heart problems receive the justice they deserve. To learn more, please contact Wright & Schulte LLC as soon as possible for a free, no-obligation AndroGel lawsuit consultation to ensure you are treated fairly and receive all of the compensation the law allows.
What is AndroGel?
AndroGel is a testosterone replacement therapy that is now marketed by AbbVie, Inc. Like other testosterone treatments, AndroGel is approved to treat men who present with low or no testosterone due to an underlying medical condition. A topical gel, AndroGel is applied once per day to the upper arm and shoulder. Since its approval in 2000, AndroGel sales have propelled it to blockbuster status, with $1.15 billion in 2012 sales. By 2013, it ranked as AbbVie’s second-best-selling drug.
According to company data, AbbVie spent $80 million on direct-to-consumer advertising for AndroGel in 2013. The company’s promotional efforts included a disease-awareness campaign to alert men to the symptoms of low testosterone, including low libido and depression. However, a number of AndroGel lawsuits claim that these advertising efforts constituted intentional “disease mongering,” and caused many men to seek treatment with AndroGel despite having no medical need for the drug.
The FDA had expressed concern in the past about some of the tactics used to market AndroGel, even before the drug was launched on the market. In 1997, for example, the company that developed AndroGel received a warning letter from the agency for a press release that touted the medication as a treatment for low testosterone levels associated with aging. Three years later, the FDA sent another warning letter which took issue with similar claims that the agency said were misleading, and reiterated that AndroGel was only approved to treat low testosterone caused by an associated illness or injury.
AndroGel Lawsuits Mount after FDA Alert
The FDA decided to take a closer look at drugs like AndroGel after two studies found that the use of these medications might cause heart attacks and other potentially fatal heart problems in some men. One of these, published in the Journal of the American Medical Association in January 2014, found a 30% increased risk of stroke, heart attack and death in older men undergoing testosterone treatment who had pre-existing heart problems. The second appeared in PLOS One in November 2013, and reported an increased risk of heart attack in older men, as well as in younger men with pre-existing heart disease, who underwent testosterone therapy.
Soon after the FDA announced its review, a number of AndroGel lawsuits were filed on behalf of men who allegedly suffered serious heart problems due to their use of the drug, including:
- Heart attacks
- Heart failure
- Deep vein thrombosis
- Pulmonary embolism
Among other things, plaintiffs in AndroGel lawsuits claim that the aggressive marketing tactics used to drive sales of the drug caused many men to be prescribed AndroGel, even though they were not suffering from low testosterone levels. The lawsuits also accuse AbbVie and other defendants of downplaying the drug’s risks, and of concealing knowledge that AndroGel had a “serious propensity” to harm.
Legal Consultations Now Available to Victims of AndroGel Attacks, Strokes and Death
Wright & Schulte LLC is offering free AndroGel lawsuit consultations to victims of serious heart events related to the use of this low testosterone therapy, as well as their families. To explore your legal options, please contact Wright & Schulte LLC today by completing the online form on the right, or call toll free, 1-800-399-079.